|[August 08, 2014]
Acacia Subsidiary Enters into Settlement and Patent License Agreement with Arthrex, Inc.
NEWPORT BEACH, Calif. --(Business Wire)--
Research Corporation (NASDAQ:ACTG) announced today that its Bonutti
Skeletal Innovations LLC subsidiary has entered into a settlement and
patent license agreement with Arthrex, Inc. The agreement resolves
litigation that was pending in the United States District Court for the
Middle District of Florida.
ABOUT ACACIA RESEARCH CORPORATION
Founded in 1993, Acacia Research (News - Alert) Corporation (NASDAQ: ACTG) is the
industry leader in patent
licensing. An intermediary in the patent marketplace, Acacia
partners with inventors and patent owners to unlock the financial value
in their patented inventions. Acacia bridges the gap between invention
and application, facilitating efficiency and delivering monetary rewards
to the patent owner.
For more information, visit: www.acaciaresearch.com.
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995
This news release may contain forward-looking statements within the
meaning of the "safe harbor" provisions of the Private Securities
Litigation Reform Act of 1995. Such statements are based upon our
current expectations and speak only as of the date hereof. Our
actual results may differ materially and adversely from those expressed
in any forward-looking statements as a result of various factors and
uncertainties, including the recent economic slowdown affecting
technology companies, our ability to successfully develop products,
rapid technological change in our markets, changes in demand for our
future products, legislative, regulatory and competitive developments
and general economic conditions. Our Annual Report on Form 10-K,
recent and forthcoming Quarterly Reports on Form 10-Q, recent Current
Reports on Forms 8-K and 8-K/A, and other SEC (News - Alert) filings discuss some of
the important risk factors that may affect our business, results of
operations and financial condition. We undertake no obligation to
revise or update publicly any forward-looking statements for any reason.
[ Back To TMCnet.com's Homepage ]